Turn Therapeutics Inc.
General ticker "TTRX" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $113.9M (TTM average)
Turn Therapeutics Inc. follows the US Stock Market performance with the rate: 11.0%.
Estimated limits based on current volatility of 4.8%: low 4.71$, high 5.18$
Short-term TTRX quotes
Long-term TTRX plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $2.31MM | $1.80MM | $5.86MM |
| Operating Income | $-2.31MM | $-1.80MM | $-5.86MM |
| Non-Operating Income | $0.02MM | $0.03MM | $2.66MM |
| R&D Expense | $0.01MM | $0.25MM | $0.27MM |
| Income(Loss) | $-2.29MM | $-1.77MM | $-3.19MM |
| Profit(Loss)* | $-2.29MM | $-1.77MM | $-3.19MM |
| Stockholders Equity | $0.09MM | $-0.18MM | $4.69MM |
| Assets | $2.01MM | $2.05MM | $12.16MM |
| Operating Cash Flow | $-1.38MM | $-1.36MM | $-2.56MM |
| Capital expenditure | $0.04MM | $0.10MM | $0.15MM |
| Investing Cash Flow | $-0.04MM | $-0.10MM | $-0.15MM |
| Financing Cash Flow | $0.50MM | $1.15MM | $6.92MM |
| Earnings Per Share** | $-0.17 | $-0.13 | $-0.23 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.